Literature DB >> 23516235

Complete Genome Sequence of a Canine-Origin H3N2 Feline Influenza Virus Isolated from Domestic Cats in South Korea.

Seong-Jun Park1, Bo-Kyu Kang, Hye-Young Jeoung, Hyoung-Joon Moon, Minki Hong, Woonseong Na, Bong-Kyun Park, Haryoung Poo, Jeong-Ki Kim, Dong-Jun An, Dae-Sub Song.   

Abstract

A canine-origin Korean H3N2 feline influenza virus (FIV), A/feline/Korea/01/2010 (H3N2), was isolated in 2010 from a dead cat with severe respiratory disease. Here, we report the first complete genome sequence of this virus, containing 3' and 5' noncoding regions, which will help elucidate the molecular basis of the pathogenesis, transmission, and evolution of FIV.

Entities:  

Year:  2013        PMID: 23516235      PMCID: PMC3593319          DOI: 10.1128/genomeA.00253-12

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Influenza A virus (IAV), a member of the family Orthomyxoviridae, is an enveloped virus with eight segmented, negative-sense, single-stranded RNA genes. IAV is a clinically and economically important pathogen which infects many animals, including humans, pigs, horses, marine mammals, and poultry (1). Influenza had long been absent from the list of infectious diseases considered as possibilities in dogs and cats (2). However, this has been recently disproved by the isolation of IAVs in those animals (3–7). A canine-origin Korean H3N2 feline influenza virus (FIV) strain, designated A/feline/Korea/01/2010 (H3N2), was isolated at the beginning of 2010 from a lung specimen of a dead cat, which had suffered from a severe respiratory disease (6). To date, a complete genome sequence containing 3′ and 5′ noncoding regions (NCRs) of H3N2 FIV has not been reported despite multiple functions of NCRs in the replication of IAVs (8–11). Therefore, it is necessary to analyze the complete genome sequence containing both 3′ and 5′ NCRs of A/feline/Korea/01/2010 (H3N2) and elucidate its molecular characteristics. Viral RNA was extracted from allantoic fluids of embryonated eggs infected with A/feline/Korea/01/2010 (H3N2) and circularized with T4 RNA ligase as described previously (12–15). To determine the complete genome sequence containing 3′ and 5′ NCRs, the PCR products produced by RNA ligation-mediated reverse transcriptase PCR (RT-PCR) were purified, cloned (16), and sequenced on an automated DNA sequencer (ABI System 3700; Applied Biosystems, Inc.) by utilizing universal primer sets (17) with slight modifications and newly designed segment-specific primers. The complete genome of A/feline/Korea/01/2010 (H3N2) is 13,629 nucleotides (nt) long, a length identical to that of the avian-origin Korean H3N2 canine influenza virus, A/canine/Korea/01/2007 (H3N2) (13); segments 1 (Seg-1) through 8 (Seg-8) are 2,341, 2,341, 2,233, 1,765, 1,565, 1,467, 1,027, and 890 nt, respectively. They encode 12 viral proteins with amino acid lengths as follows: PB2, 759; PB1, 757; N40 (18), 718; PB1-F2, 90; PA, 716; HA, 566; NP, 498; NA, 469; M1, 252; M2, 97; NS1, 230; and NS2 (nuclear export protein [NEP]), 121. While the lengths of the 3′ and 5′ NCRs of the viral RNA of A/feline/Korea/01/2010 (H3N2) were variable (19 to 45 and 20 to 58 nt at the 3′ and 5′ NCRs, respectively) in the different genome segments, the terminal 12 and 13 nt of the 3′ and 5′ ends, respectively, were highly conserved (3′-UCGYUUUCGUCC- and -GGAACAAAGAUGA-5′) among all eight genome segments, which is consistent with previous studies (13, 14, 19, 20). Surprisingly, 1 nt was changed between the start codon (UAC) and the conserved region (UCGYUUUCGUCC) in the 3′ NCR of Seg-1 and also in Seg-6 of A/feline/Korea/01/2010 (H3N2) compared to A/canine/Korea/01/2007 (H3N2). This is the first report of the complete genome sequence containing the 3′ and 5′ NCRs of H3N2 FIV. We hope that these data will provide important insights into the molecular basis of the pathogenesis, transmission, and evolution of FIV as well as other IAVs.

Nucleotide sequence accession numbers.

The complete genome sequence of the A/feline/Korea/01/2010 (H3N2) strain described here has been deposited in GenBank under the accession numbers KC422453 to KC422460 for Seg-1 to Seg-8.
  20 in total

1.  Large-scale sequence analysis of avian influenza isolates.

Authors:  John C Obenauer; Jackie Denson; Perdeep K Mehta; Xiaoping Su; Suraj Mukatira; David B Finkelstein; Xiequn Xu; Jinhua Wang; Jing Ma; Yiping Fan; Karen M Rakestraw; Robert G Webster; Erich Hoffmann; Scott Krauss; Jie Zheng; Ziwei Zhang; Clayton W Naeve
Journal:  Science       Date:  2006-01-26       Impact factor: 47.728

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Transmission of equine influenza virus to dogs.

Authors:  P C Crawford; Edward J Dubovi; William L Castleman; Iain Stephenson; E P J Gibbs; Limei Chen; Catherine Smith; Richard C Hill; Pamela Ferro; Justine Pompey; Rick A Bright; Marie-Jo Medina; Calvin M Johnson; Christopher W Olsen; Nancy J Cox; Alexander I Klimov; Jacqueline M Katz; Ruben O Donis
Journal:  Science       Date:  2005-09-26       Impact factor: 47.728

4.  Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5' ends of the viral RNAs.

Authors:  L S Tiley; M Hagen; J T Matthews; M Krystal
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

6.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Rapid method for the characterization of 3' and 5' UTRs of influenza viruses.

Authors:  Christopher Szymkowiak; Wan-Sang Kwan; Qin Su; Timothy J Toner; Alan R Shaw; Rima Youil
Journal:  J Virol Methods       Date:  2003-01       Impact factor: 2.014

8.  The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity.

Authors:  U Desselberger; V R Racaniello; J J Zazra; P Palese
Journal:  Gene       Date:  1980-02       Impact factor: 3.688

9.  Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication.

Authors:  H Zheng; P Palese; A García-Sastre
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

10.  Complete genome sequence of a mammalian species-infectious and -pathogenic H6N5 avian influenza virus without evidence of adaptation.

Authors:  Seong-Jun Park; Bong-Kyun Park; Dae-Sub Song; Haryoung Poo
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

View more
  4 in total

1.  New insights into the nonconserved noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of influenza A viruses.

Authors:  Lili Zhao; Yousong Peng; Kai Zhou; Mengmeng Cao; Jingfeng Wang; Xue Wang; Taijiao Jiang; Tao Deng
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

2.  Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence.

Authors:  Kurtis H Feng; Gaelle Gonzalez; Lingquan Deng; Hai Yu; Victor L Tse; Lu Huang; Kai Huang; Brian R Wasik; Bin Zhou; David E Wentworth; Edward C Holmes; Xi Chen; Ajit Varki; Pablo R Murcia; Colin R Parrish
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Serological survey of canine H3N2, pandemic H1N1/09, and human seasonal H3N2 influenza viruses in cats in northern China, 2010-2014.

Authors:  Xuxiao Zhang; Ye Shen; Lijie Du; Ran Wang; Bo Jiang; Honglei Sun; Juan Pu; Degui Lin; Ming Wang; Jinhua Liu; Yipeng Sun
Journal:  Virol J       Date:  2015-04-01       Impact factor: 4.099

4.  Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Authors:  Dimitris Petridis; Paul Zarogoulidis; Anastasios Kallianos; Ioannis Kioumis; Georgia Trakada; Dionysios Spyratos; Antonis Papaiwannou; Konstantinos Porpodis; Haidong Huang; Aggeliki Rapti; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Ther Clin Risk Manag       Date:  2014-02-07       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.